baber/WOPTO huggingface dataset:
Patent NZ-263606-A (NZ)
Title: Injection of powdered drug by entrainment in supersonic gas flow
Inventor: BELLHOUSE BRIAN JOHN
IPC: A61M5/307
Filed: 1994-04-08
Abstract: A needleless syringe having a membrane (34) which is ruptured by gas pressure to generate a gas flow in which particles can be entrained so as to be injected. The invention also provides a product comprising a sealed unit comprising two diaphragms which are directly or indirectly sealed to one another around their edges, and which contain particles for transdermal injection.
Patent NZ-264389-A (NZ)
Title: Annular array of reaction containers, each container having a closure piercable by a pipetting needle
Inventor: FASSBIND WALTER
IPC: B01L3/00
Filed: 1994-09-05
Abstract: Disposable arrangemet of reaction vessels of identical shape and dimensions for carrying out temperature cycling of a liquid mixture contained in the reaction vessels, each reaction vessel having a first, conical wall region and a second, cylindrical wall region, which cylindrical wall region forms the opening of the reaction vessel at one end, the wall thickness of the first wall region being less than the wall thickness of the second wall region, and the opening of the reaction vessel being able to reeive a closure which is suitable for closing the reaction vessel gas-tightly when it is placed on the opening of the reaction vessel. To facilitate handling and access to the liquids contained in the reaction vessels, the arrangement of reaction vessels is characterised in that it is annular, and in that the closure (87) of each of the reaction vessels (21) can be pierced by a pipetting needle (32). <IMAGE>
Patent NZ-329656-A (NZ)
Title: Oxazole and thiazoles derivatives containing a fibrinogen receptor antagonist template
Inventor: ALI FADIA EL FEHAIL
IPC: A61K31/47
Filed: 1998-01-28
Abstract: Compounds are disclosed which are vitronectin receptor antagonists useful in the treatment of inflammation, cancer, cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, such as osteoporosis. These compounds comprise a fibrinogen receptor antagonist template linked to a heterocyclic moiety. The compound claimed according to formula (II). G is S or O; W is CHRga-U-CHRgb-V- or formula (IV) A is a fibrinogen receptor antagonist template (illustrated according to formula (a) to (i) Wherein 	R1 and R1, are R* or R, or together are =O; 		R2 and R2, are R* or R, or together are =O; 		R3 and R3, are R* or R, or together are =O; 		R4 and R4, are R* or R, or together are =O; 		R5 and R5, are R* or R, or together are =O; 		R is at least one substituent chosen from the group of R7, or Q-C1-4alkyl, Q-C1-4alkenyl, Q-C2-4alkynyl, optional substituted by one or more =O, R11 or R7; and 	R* is H, Q-C1-6alkyl, Q-C1-6oxoalkyl, Q-C2-6oxoalkyl, Q-C2-6oxoalkenyl, Q-C3-4oxoalkynyl, Q-C2-4oxoalkynyl, Q-C3-6oxoalkynyl, Ar or Het, optional substituted by one or more R11
Patent NZ-335346-A (NZ)
Title: Transparent solid soap and transparent soap material; obtained by saponifying fatty acid or animal/vegetable oil with sodium hydroxide and an organic amine
Inventor: SHIMOSATO ISAO
IPC: C11D13/16
Filed: 1997-09-05
Abstract: The transparent soap material is obtained by saponifying fatty acid or animal/vegetable oil with alkali, which comprises mainly a salt of fatty acid, wherein i) the alkali is sodium hydroxide and organic amine, and the molar ratio of the sodium hydroxide to the organic amine is from 1:0.8 to 1:1.8, and ii) the quantity of the alkali is 2.2 to 2.7 saponifying equivalents of the fatty acid or the animal/vegetable oil. Also described is a transparent solid soap obtained by molding the above described transparent soap material.
Patent NZ-336714-A (NZ)
Title: Screw thread having a ridge with two peaks separated by a trough
Inventor: PAPAFOTIOU FOTIOS
IPC: B21H3/02
Filed: 1998-11-10
Abstract: A screw thread having a twin start helical thread configuration consisting of two ridges 12 and 13 of equal height helically winding around a core 19.  The thread is continuous for its length on the screw.  The crest of each ridge 21 and 31 carries a pair of peaks along its length and is separated by a trough 29 the depth of which is less than the height of the ridge from root to crest. It has particular use as a screw for timber, and is especially suited to fixing railway rails to sleepers.
Patent NZ-501161-A (NZ)
Title: Chimeric human trkA-IgG polypeptides which bind to human nerve growth factor.
Inventor: PRESTA LEONARD
IPC: A61K38/18
Filed: 1995-03-17
Abstract: The specification describes the use of a polypeptide comprising the second immunoglobulin-like domain of a human trkA sequence joined an immunoglobulin amino acid sequence to treat hyperalgesia.
Patent NZ-503585-A (NZ)
Title: Entertainment system where controls on manual input controller emit light to give visual sensations in response to displayed image on monitor
Inventor: OGATA HIROKI
IPC: A63F13/5372
Filed: 1999-07-29
Abstract: A main memory stores an operation guidance program for displaying an operation guidance on a display monitor (6) and enabling control members of a manual control input device (2) to emit continuous or flickering light in relation to the operation guidance.  Based on a command from the manual control input device (2), a CPU executes the operation guidance program stored in the main memory.  The operation guidance program enables the control members to emit continuous or flickering light sequentially and displays an operation guidance for at least the control members which are emitting continuous of flickering light on the display monitor.  Not only the operation guidance is displayed on the display monitor (6), but also visual sensations are given to the game player by controlling the control members to emit continuous or flickering light on the manual control input device (2).
Patent NZ-504258-A (NZ)
Title: Exendin 3 and 4 agonist compounds for the treatment of diabetes
Inventor: BEELEY NIGEL ROBERT ARNOLD
IPC: A61P3/10
Filed: 1998-11-13
Abstract: Described are compounds which have activity as exendin agonists.  These compounds are useful in the preparation of medicaments for treatment of Type I and II diabetes, in treatment of disorders which would be benefited by agents which lower plasma glucose levels and in treatment of disorders which would be benefited with agents useful in delaying and/or slowing gastric emptying.
Patent NZ-505135-A (NZ)
Title: Composition comprising a proton pump inhibitor (H+,K+-ATPase inhibitor) which provides two or more discrete release pulses in the small and/or large intestines
Inventor: LUNDBERG PER JOHAN
IPC: A61K31/4439
Filed: 1998-12-17
Abstract: An enteric coated pharmaceutical dosage form comprising an H+, K+-ATPase inhibitor and having an instant inhibitor-releasing part and at least one delayed inhibitor-releasing part. The dosage form is capable of giving a discontinuous release of H+, K+-ATPase inhibitor in the form of at least two consecutive pulses separated in time from 0.5 up to 12 hours, and the H+, K+-ATPase inhibitor is a compound of Formula (I). Wherein; Het1 is Formula (II) or Formula (III); Het2 is Formula (IV) or Formula (V); X is Formula (VI) or Formula (VII); N in the benzimidazole moiety means that one of the ring carbon atoms substituted by R6-R9 optionally may be exchanged for a nitrogen atom without any substituents; R1, R2 and R3 are the same or different and selected from the group consisting of hydrogen, alkyl, alkoxy, fluorine-substituted alkoxy, alkythio, alkoxyalkoxy, dialkylamino, piperidino, morpholino, halogen, phenyl and phenylalkoxy; R4 and R5 are the same or different and selected from the group consisting of hydrogen, alkyl and arylalkyl; R6' is selected from the group consisting of hydrogen, halogen, trifluoromethyl, alkyl and alkoxy; R6-R9 are the same or different and selected from the group consisting of hydrogen, alkyl, alkoxy, halogen, haloalkoxy, alkylcarbonyl, alkoxycarbonyl, oxazolinyl and trifluoroalkyl or adjacent groups R6-R9 form ring structures; R10 is hydrogen or forms an alkylene chain together with R3; and R11 and R12 are the same or different and selected from the group consisting of hydrogen, halogen and alkyl.
Patent NZ-511077-A (NZ)
Title: N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
Inventor: BERTINI RICCARDO
IPC: A61K31/16
Filed: 1999-10-14
Abstract: Compounds of formula (1) wherein: R2 is an aryl group, R is a straight or branched C1-6alkyl, trifluoromethyl, cyclohexyl, o-tolyl, 3-pyridyl, 2-pyridyl-ethyl, p-cyano-phenylmethyl, p-aminophenylmethyl, 3-cyano-1-propyl, 4-aminobutyl, alkoxyethylene CH3-(CH2)ni-(OCH2CH2)mi- group, or P1P2N-CH2-CH2- group, and R' is H or straight or branched C1-3alkyl. The compounds are used in the preparation of medicaments for the inhibition of neutrophils chemotaxis and degranulation induced by interleukin-8.
Patent NZ-511623-A (NZ)
Title: Methods of identifying antigen gene sequences from Mycoplasma
Inventor: MOORE ROBERT JOHN
IPC: A61K48/00
Filed: 1999-11-19
Abstract: Expression clones in library can be identified by a method of screening. The method comprises providing a source of nucleotide sequences, providing an expression vector including a small marker tag. The nucleotide sequence is introduced into the expression vector. The expression vector is transformed into a host cell to crate an expression library. An expression clone is then located by detecting the expression of a fusion protein comprising a marker co-expressed with an expression protein. The method can be further used to identify therapeutic antigenic gene sequences encoding antigenic proteins of a disease from a sample of nucleotides sequences. The method further comprises inoculating an animal with the expression vector that expresses the antigenic expression protein and then challenging the animal with the disease. Expression vectors that provide a therapeutic effect induced by the vaccination are identified. Also described are nucleotide and amino acid sequences of Mycoplasma and antibodies specific for the polypeptides encodes by the amino acid sequences. The polypeptide, antibodies and DNA molecules are useful for infection particularly Mycoplasma hypneumoniae infections.
Patent NZ-512079-A (NZ)
Title: Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
Inventor: HIRSCH RICHARD
IPC: A61K9/20
Filed: 1999-12-23
Abstract: Solid pharmaceutical composition for oral administration having a sustained-release matrix, containing tilidine mesylate as an active ingredient. The content of tilidine mesylate ranges from 50-500mg of tilidine-HCl. The sustained-release matrix contains retardation agents hydrophilic and or hydrophobic polymers, and or fatty acids, glycerol esters of fatty acids, minerals and vegetable oils, waxes and or polyalkylene glycols.
Patent NZ-513032-A (NZ)
Title: Non-irritating anti-microbial compostitions
Inventor: MANSOURI ZAHRA
IPC: A61K8/24
Filed: 1996-06-13
Abstract: Active  materials such as herbal extracts,  allantoin, citric   acid,  vitamins,  anti-inflammatory   agents,   sun blocking agents, emollients or antimicrobial agents  may  be delivered  to  the  skin  of  a  subject  in  a  composition comprising   an  effective  amount  of  particular   ceramic hydroxyapatite.   The ceramic hydroxyapatite  particles  are uniform  and  spherical with a mean diameter of  from  1  to about   10  micrometers.   The  composition  may  optionally contain hyaluronic acid. A  preferred  skin  cleansing and moisturizing  composition, comprises triclosan as an antimicrobial agent.
Patent NZ-517463-A (NZ)
Title: Promoter and terminator sequences functioning in filamentous fungi
Inventor: WATANABE MANABU
IPC: C12N15/80
Filed: 2000-09-07
Abstract: A promoter having promoter activity comprises a nucleotide sequence selected from: a nucleotide sequence of SEQ ID NO:1, a nucleotide sequence having 70% homology to SEQ ID NO:1, a modified nucleotide sequence of SEQ ID NO:1 and a nucleotide sequence that hybridizes with the sequence do SEQ ID NO:1. Also described is a terminator having terminator activity comprising a nucleotide sequence of SEQ ID NO:2, a nucleotide sequence having 70% homology to SEQ ID NO:2, a modified nucleotide sequence of SEQ ID NO:2 and a nucleotide sequence that hybridizes with the sequence do SEQ ID NO:2. The promoter and terminator can function in a filamentous fungus that belongs to Agonomycetes. Expression vectors can comprise the promoter, the terminator or both. A host, preferably Mycelia sterilia can be transformed with the expression vectors.
Patent NZ-517581-A (NZ)
Title: Progressive punch
Inventor: CHEUNG NELSON
IPC: B65B13/30
Filed: 2002-03-04
Abstract: A punch is for use with an associated strapping tool for forming a seal between two portions of strapping material; the strapping tool includes a jaw (11) having a fixed support (16) and a movable support (12) movable toward and away from the fixed support in a direction of movement to engage the two portions of strapping material. The punch comprises two punching heads (14) attached to one another, the first punching head has a height defined by a distance between the outermost peripheral point of the first punching head and a plane perpendicular to the direction of movement, and the second punching head has a height defined by a distance between an outermost peripheral point of the second punching head and the plane perpendicular to the direction of movement, wherein the height of the first punching head is different from the height of the second punching head.
Patent NZ-518363-A (NZ)
Title: Elisa for vascular endothelial growth factor using monoclonal and polyclonal antibodies
Inventor: FEI DAVID TAI WAI
IPC: G01N33/68
Filed: 2000-11-15
Abstract: The vascular endothelial growth factor (VEGF) activity in a patient's bloodstream or other biological sample can serve as a diagnostic and prognostic index for cancer, diabetes, heart conditions, and other pathologies. Antibody-sandwich ELISA method and kits for VEGF as an antigen were developed to detect VEGF levels in biological samples from animal models and human patients and are used as a diagnostic/prognostic index.
Patent NZ-521830-A (NZ)
Title: Hair growth stimulant compositions
Inventor: IMAMURA KOJI
IPC: A61K31/513
Filed: 2001-04-05
Abstract: A hair growth stimulant composition comprising 10 to 50% by mass of water and 3% by mass or more of minoxidil, further comprising 8 to 30% by mass of a polyhydric alcohol, and having a pH of 5.5 to 6.5, wherein the composition does not precipitate crystals upon storage.
Patent NZ-521863-A (NZ)
Title: Illuminated sign with emergency lighting function
Inventor: SACHA JORDAN
IPC: G09F13/04
Filed: 2001-03-30
Abstract: An internally illuminated sign carrying element of an emergency light and sign assembly is provided, in which a base unit (11) is arranged to be mounted to a ceiling (33) and the sign body (12) clips onto the base. The sign carrier element (12) extends below the base unit (11) and is removable from the base unit (11). Electrical connection between the removable sign carrier (12) and the electronic module (16) of the base unit (11) is via a pair of cooperating electrical connectors (24, 25). The sign element (12) is formed in a transparent, semi-transparent or translucent material and is moulded as a pair of shell halves which when assembled together, encapsulate two light sources (26, 27), an upper one of which (light source 26) performs a normal sign illuminating function and the other of the two light sources (27), performs an emergency illuminating function whereby the sign is illuminated, as well as a surrounding area of the floor under emergency conditions. The base unit (11), houses batteries (14), transformers (15) and an electronic module (16) carrying the communications control, battery charging, device monitoring and electronic ballast circuits required to perform emergency lighting and illuminated sign functions.
Patent NZ-521874-A (NZ)
Title: Mailbox with a lockable slotted pivoted flap providing delivery and retrieval access which is further covered by a pivoting lid.
Inventor: CAMPBELL DONALD IAN
IPC: A47G29/12
Filed: 2002-10-09
Abstract: A mailbox including a housing with an interior cavity form accommodating mail delivered to the mailbox, the housing having mail delivery opening through which mail can be delivered into the cavity, and a mail retrieval opening through which delivered mail can be retrieved from the cavity, the mailbox also having a lid which is closable over the mail delivery and mail retrieval openings.
Patent NZ-523593-A (NZ)
Title: Process for the extraction and concentration of unsaponifiables from the residues and by-products of animal and vegetable products
Inventor: ROHR RODOLFO
IPC: B01D3/10
Filed: 2001-06-04
Abstract: Processes for the extraction and concentration of unsaponifiable substances, containing liposoluble vitamins and provitamins, growth factors and animal and vegetable hormones, obtained from animal or vegetable products, or from the residues of the industrialization of these same products, without the need for solvents by means of high vacuum distillation/evaporation.
Patent NZ-525831-A (NZ)
Title: Line differential protection system for a power transmission line
Inventor: ROBERTS JEFFREY B
IPC: H02H3/30
Filed: 2001-10-15
Abstract: In a power line current differential protection system, all three phase current values (IA, IB, and IC) are obtained from both the local end and the remote end of a power transmission line (12). The magnitude of the ratio of the remote current values to the local current values is calculated. Also, the angle difference between the local and the remote current values for each phase are calculated. Comparison elements (40, 42) then compare the ratio and angle values against pre-selected values, which establish a restrain region in the current ratio plane. Current values that result in the ratio being within the region do not result in a tripping signal for the circuit breaker on the power transmission line (12), while current values that result in a ratio outside of the region result in a tripping of the circuit breaker. Similar circuitry is used for negative sequence current quantities, with the negative sequence pre-selected values being set substantially lower to produce a more sensitive response to possible faults in the line.
Patent NZ-525864-A (NZ)
Title: Fire extinguishing methods utilizing hydrofluoroethers
Inventor: ROBIN MARK L
IPC: C07C41/06
Filed: 2001-11-14
Abstract: Fire extinguishing agents, methods for extinguishing fires using saturated or unsaturated, fluorinated, C4 and/or C5 hydrofluoroethers and methods of making hydrofluoroethers are disclosed. The hydrofluoroethers are efficient, economical, non-ozone depleting fire extinguishing agents and they may be used alone or in blends with other fire extinguishing agents in total flooding and portable systems.
Patent NZ-527815-A (NZ)
Title: N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
Inventor: CHEN ZHAOGEN
IPC: C07D471/04
Filed: 2002-03-15
Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof, which are antagonists of the 5-HT6 receptor are disclosed, wherein: X is selected from the group consisting of -O-, -NH-, -S-, -SO2-, -CH2-, -CH(F)-, -CH(OH)-, and -C(O)-; R1 is selected from the group consisting of optionally substituted phenyl provided that R1 is not C1-C4 alkoxy optionally substituted phenyl, optionally substituted naphthyl, optionally substituted 5 to 6 membered monocyclic aromatic heterocycle having one heteroatom selected from the group consisting of nitrogen, oxygen, and sulfur and which 5 to 6 membered monocyclic aromatic heterocycle is optionally benzofused; R2 is selected from the group consisting of hydrogen and C1-C3 alkyl; R3 is selected from the group consisting of hydrogen, fluoro, and methyl; R4 is selected from the group consisting of hydrogen, allyl,C2-C4 alkyl, fluorinated C2-C4 alkyl, optionally substituted phenyl, optionally substituted phenylsulfonyl, optionally substituted benzyl, and optionally substituted 5 to 6 membered monocyclic aromatic heterocycle having one or two heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur, provided that R4 is not optionally substituted phenylsulfonyl when X is -SO2-, -CH2-, CH(F)-, - CH(OH)-, or -C(O)-.
Patent NZ-527987-A (NZ)
Title: Equestrian saddle with angle between side panels adjustable
Inventor: WALKER DANIEL ALEXANDER LLOYD
IPC: B68C1/02
Filed: 2002-03-01
Abstract: An equestrian saddle comprises a modular construction including a tree (2) having two side panels (8) connected by a bridge (12) of hinged construction whereby the side panels (8) are angularly adjustable, and a seat plate (50) secured to the side panels (8).
Patent NZ-528327-A (NZ)
Title: Plastics viscosity control method and apparatus
Inventor: IBAR JEAN-PIERRE
IPC: B29C48/525
Filed: 2003-09-18
Abstract: An apparatus for reducing viscosity of a polymer melt comprising: an inlet means; a gap means; a drive means; a rib means; an outlet means; and a feeder, wherein said inlet means defines a gap inlet through which the polymer melt passes into the gap means; wherein said gap means defines first and second surfaces which are spaced apart from each other to form a treatment cavity gap, the surfaces being movable relative to each other; wherein said drive means moves said first and second surfaces relative to each other; wherein said rib means comprises ribs attached to at least one of said surfaces in a configuration that causes local extensional acceleration and deceleration of said polymer melt simultaneously with a periodic variation in shear strain rate in said polymer melt as it passes through said treatment cavity gap; wherein said outlet means defines a gap outlet through which said polymer melt exits the gap; and wherein said feeder is connected to the inlet means, prepares the polymer melt, and transports it into the inlet means. (62) Divided out of 515874
Patent NZ-528386-A (NZ)
Title: Improvements in and relating to security container
Inventor: ACE-KIRKER WAYNE LIONEL
Filed: 2003-09-19
Abstract: Security means being a security container, the security container including at least one container means (2) having an interior (3) for storing valuables therein, the container means having at least one opening (7) thereinto, a closure means (8) covering the at least one opening into the container means, and locking means (16) to secure the closure means over the opening, the security container being configured to be fitted into a recess within a surface and the security container further including retention means, the retention means including bracing means (30a), the bracing means effecting a brace relative to one or more permanent structural features associated with the surface to impede forced removal of the security container from the recess. The locking means includes a locking pin (19) and a lock body (17), the locking pin being independent of the lock body when the locking means is unlocked and being insertable through an aperture in the closure means and into the lock body aligned to receive the locking pin as required to lock the locking means and secure the closure means over the opening of the security container.
Patent NZ-530585-A (NZ)
Title: Conveying installation for transporting goods
Inventor: TRIEB HERBERT
IPC: B65G21/04
Filed: 2004-01-14
Abstract: A conveying installation for transporting goods, comprising: a conveyor belt disposed to move along a travel direction; a plurality of supporting bars fastened on said conveyor belt transversely to the 5 travel direction; running rollers supported at lateral ends of said supporting bars; two vertically spaced-apart supporting tracks each formed with a pair of supporting cables including an upper pair and a lower pair for supporting said running rollers; spaced-apart retaining frames fastened to said supporting cables; and at least one further supporting cable fastened to said retaining frames above said upper pair of supporting cables.